Abstract Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-
2 infection and is associated with both acute and chronic disorders affecting the nervous …

Infection with SARS-CoV-2 ranges from an asymptomatic condition to a severe and
sometimes fatal disease, with mortality most frequently being the result of acute lung injury …

Background While much of the scientific focus thus far has been on cognitive sequelae in
patients with severe COVID‐19, subjective cognitive complaints are being reported across …

Viral infections of the respiratory tract can have multisystemic effects, including on the central
nervous system (CNS), and thus may precipitate a spectrum of psychiatric and neurological …

While neuropathological examinations in patients who died from COVID-19 revealed
inflammatory changes in cerebral white matter, cerebral MRI frequently fails to detect …

The novel coronavirus disease 19 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), can have two phases: acute (generally 4 weeks …

Long COVID-19 is a recognized entity that affects millions of people worldwide. Its broad
clinical symptoms include thrombotic events, brain fog, myocarditis, shortness of breath …

Background Thrombotic complications of COVID-19 infection have become increasingly
apparent as the disease has infected a growing number of individuals. Although less …

Background Neurological manifestations are common in patients with coronavirus disease
2019 (COVID-19), but little is known about pathophysiological mechanisms. In this single …

Introduction: The COVID-19 pandemic remains aglobal challenge. While there are mRNA
agents on the horizon as apotential prevention, adefinitive drug therapy is an unmet medical …